Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating rheumatism

A technology for rheumatism and medicine, applied in the field of medicine preparation, can solve the problems of large toxic and side effects, long curative effect, etc., and achieve the effect of short symptom relief period

Inactive Publication Date: 2017-05-17
ZHENGZHOU ZHENGXIAN PHARMA CO LTD
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, Western medicine mostly uses non-steroidal anti-inflammatory analgesics for symptomatic treatment of bone and joint pain, and there are also local application of non-steroidal anti-inflammatory analgesics, but there are adverse phenomena such as long-lasting curative effect and severe side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] A medicine for treating rheumatism, the main raw materials in parts by weight are: 8 parts of tea polyphenols, 10 parts of etamsulfame, 4 parts of diazepam, 20 parts of lidocaine, 5 parts of ofloxacin, and 8 parts of zeosterol , 4 parts of lycopene, 6 parts of ganoderma polysaccharide.

[0017] A preparation method of a medicine for treating rheumatism, the specific steps are:

[0018] First, in a pharmaceutical-grade clean area, tea polyphenols, phensulfame, diazepam, lidocaine, ofloxacin, zeosterol, lycopene, and ganoderma polysaccharide were weighed according to the above metering ratio, sieved, and mechanically mixed. After uniformity, add ultrapure water, place in a pharmaceutical mixer, mix for 4 minutes, control RSD≤5%, after mixing, press into tablets and dry at low temperature, the temperature is controlled at 4°C, and the medicine for treating rheumatism is obtained after packaging.

Embodiment 2

[0020] A medicine for treating rheumatism, the main raw materials according to parts by weight are: 9 parts of tea polyphenols, 12 parts of ethylamine sulfate, 5 parts of diazepam, 23 parts of lidocaine, 6 parts of ofloxacin, and 9 parts of zeosterol , 6 parts of lycopene, 6 parts of ganoderma polysaccharide.

[0021] A preparation method of a medicine for treating rheumatism, the specific steps are:

[0022] First, in a pharmaceutical-grade clean area, tea polyphenols, phensulfame, diazepam, lidocaine, ofloxacin, zeosterol, lycopene, and ganoderma polysaccharide were weighed according to the above metering ratio, sieved, and mechanically mixed. After uniformity, add ultrapure water, place in a pharmaceutical mixer, mix for 4 minutes, control RSD≤5%, after mixing, press into tablets and dry at low temperature, the temperature is controlled at 4°C, and the medicine for treating rheumatism is obtained after packaging.

Embodiment 3

[0024] A medicine for treating rheumatism, the main raw materials in parts by weight are: 10 parts of tea polyphenols, 14 parts of etamsulfame, 8 parts of diazepam, 25 parts of lidocaine, 7 parts of ofloxacin, and 10 parts of zeosterol , 7 parts of lycopene, 8 parts of ganoderma polysaccharide.

[0025] A preparation method of a medicine for treating rheumatism, the specific steps are:

[0026] First, in a pharmaceutical-grade clean area, tea polyphenols, phensulfame, diazepam, lidocaine, ofloxacin, zeosterol, lycopene, and ganoderma polysaccharide were weighed according to the above metering ratio, sieved, and mechanically mixed. After uniformity, add ultrapure water, place in a pharmaceutical mixer, mix for 6 minutes, control RSD≤5%, after mixing, press into tablets and dry at low temperature, the temperature is controlled at 6°C, and the medicine for treating rheumatism is obtained after packaging.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating rheumatism. The medicine for treating the rheumatism contains the following main raw materials in parts by weight: 8-13 parts of tea polyphenol, 10-16 parts of etamsylate, 4-11 parts of diazepam, 20-30 parts of lidocaine, 5-10 parts of ofloxacin, 8-12 parts of corn sterol, 4-10 parts of lycopene and 6-9 parts of lucidum polysaccharide. The medicine is capable of effectively relieving swelling and pains of limbs and joints caused by rheumatism and rheumatoid diseases and effectively improving the life quality of patients with rheumatism and rheumatoid diseases, the symptoms relief cycle is short after the medicine is taken, and obvious toxic and side effects are not found at present.

Description

technical field [0001] The invention relates to the field of medicine preparation, in particular to a medicine for treating rheumatism. Background technique [0002] Rheumatoid arthritis is an allergic disease and is one of the main manifestations of rheumatic fever in the joints. It usually starts with acute fever and joint pain. The typical manifestations are mild or moderate fever, migratory polyarthritis, and affected joints Most of them are large joints such as knees, ankles, shoulders, elbows, and wrists. It is common to transfer from one joint to another. The local lesion is red, swollen, hot, and severe pain, symmetrical, persistent swelling and tenderness, morning stiffness often long After more than 1 hour, the typical hand joint deformity of RA appears. In severe patients, the joints are fibrous or bony ankylosing, and the joint function is lost due to muscle atrophy and spasm around the joints, resulting in inability to take care of themselves. If rheumatic acti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/205A61K31/5513A61K31/167A61K31/5383A61K31/575A61K31/01A61K31/715A61K36/82A61P19/02A61P19/00
CPCA61K31/205A61K31/01A61K31/167A61K31/5383A61K31/5513A61K31/575A61K31/715A61K36/82A61K2300/00
Inventor 不公告发明人
Owner ZHENGZHOU ZHENGXIAN PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com